AltheaDx (United States)

Recent papers from AltheaDx (United States)

1. Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive DisorderJournal of Managed Care & Specialty Pharmacy · 2018
2. Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settingsNeuropsychiatric Disease and Treatment · 2018
3. Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix®) to Guide Treatment of Patients with Depression and/or AnxietyPharmacoEconomics · 2017
4. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utilityJournal of Psychiatric Research · 2017
5. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric DisordersThe Primary Care Companion For CNS Disorders · 2017
6. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with PolypharmacyDrugs & Aging · 2016
7. Generation of “Virtual” Control Groups for Single Arm Prostate Cancer Adjuvant TrialsPLoS ONE · 2014
8. A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile StudiesAnti-Cancer Agents in Medicinal Chemistry · 2013
9. Expression Changes in the Stroma of Prostate Cancer Predict Subsequent RelapsePLoS ONE · 2012
10. Exploring Molecular Pathways of Triple-Negative Breast CancerGenes & Cancer · 2011
11. Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3PLoS ONE · 2011
12. High-throughput toxicological classification of candidate drug compounds using gene expression, evolved neural networks, and a cell-based platform2011